Table 1.
Characteristics of study population (n = 73)
| Men n = 46 | Women n = 27 | P value | |
|---|---|---|---|
| Age (years) | 55 ± 7 | 52 ± 8 | 0.11 |
| Race | 0.19 | ||
| Caucasian | 31 (67) | 14 (52) | |
| African American | 12 (26) | 10 (37) | |
| Other | 3 (7) | 3 (11) | |
| BMI (kg/m2) | 32.0 ± 4.6 | 32.0 ± 4.8 | 0.99 |
| Blood pressure (mmHg) | |||
| Systolic | 125 ± 12 | 126 ± 15 | 0.79 |
| Diastolic | 76 ± 9 | 74 ± 10 | 0.37 |
| Statin use | 36 (78) | 21 (78) | 0.96 |
| Fasting laboratory data | |||
| HbA1c (%) | 6.8 ± 0.8 | 7.0 ± 0.7 | 0.26 |
| Blood glucose (mg/dL) | 110 ± 20 | 121 ± 28 | 0.08 |
| Total cholesterol (mg/dL) | 148 ± 29 | 154 ± 34 | 0.42 |
| LDL (mg/dL) | 83 ± 22 | 77 ± 27 | 0.31 |
| HDL (mg/dL) | 41 ± 11 | 49 ± 12 | 0.01* |
| Triglycerides (mg/dL) | 124 ± 69 | 124 ± 60 | 0.95 |
| Creatinine clearance rate (mL/min) | 74.8 ± 17.9 | 79.3 ± 20.6 | 0.32 |
| Duration of diabetes (years) | 7.9 ± 6.3 | 7.8 ± 6.5 | 0.93 |
| Diabetes medications | |||
| Metformin | 38 (78) | 23 (79) | 0.77 |
| Insulin | 6 (12) | 4 (14) | 0.74 |
| Sulfonylurea | 17 (35) | 9 (32) | 0.51 |
| Thiazolidinedione | 0 (0) | 3 (11) | 0.05 |
| Glucagon-like peptide 1 analog | 2 (4) | 3 (11) | 0.35 |
| Dipeptidyl peptidase 4 inhibitor | 1 (2) | 0 (0) | 0.64 |
Data are expressed as mean ± SD for continuous variables and as absolute numbers (%) for categorical variables. Comparisons across sexes were performed using the unpaired Student t test, Fisher exact test, and χ2 test for continuous, binary, and categorical variables, respectively.
*P < 0.05 between men and women.